drugset / Trial / NCT01276821

Efficacy of Nebulised Hypertonic Saline (3%) Among Children With Bronchiolitis.

NCT01276821

Phase 4 Completed 100 enrolled Dr. Aayush Khanal, MD
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To assess the efficacy of nebulized 3% hypertonic saline in improving clinical severity scores among children aged 6 weeks to 24 months with bronchiolitis.

Timeline

Start
2011-01
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hypertonic saline Unknown 4 ml Inhaled
Comparator Epinephrine Other / unclassified 1.5 mg Inhaled

Indications